Sentry BioPharma Services Earns a GSA Federal Supply Schedule Contract #GS-10F-0432X

Sentry BioPharma Services, a provider of global biopharmaceutical cGMP storage, supply chain management, prescription drug distribution and clinical packaging services, announced today that they have signed a five-year contract with the General Service Administration for inclusion on the Federal Supply Schedule, Logistics Worldwide (LogWorld).

Inclusion on this schedule will help Sentry BioPharma secure no bid contracts with many federal government agencies for the provision of temperature-controlled storage and distribution of vaccines and pharmaceutical products.

When asked about the significance of this contract, Ms. Jennifer Marcum, Sentry's CEO, stated that "earning a GSA Contract is not only a testament to Sentry BioPharma's expertise as a biopharmaceutical warehousing and logistics provider and its ability to expeditiously implement key projects.

It is also a validation of our international services, as the application process includes an extensive review of Sentry's prior experience with temperature-controlled vaccine and pharmaceutical storage and logistics, as well as a survey of our clients' satisfaction with our company." Marcum further elaborated by stating that "Sentry's biopharmaceutical storage and drug distribution services are perfectly designed and constructed to support any government agency's needs for the cGMP storage, labeling, kitting and distribution of temperature-sensitive pharmaceutical products, including vaccines and regulated medications." Finally, Marcum stressed that "by investing the resources to complete the GSA contracting process, Sentry expects to gain efficiencies when contracting with federal agencies like Department of Defense (DOD), the Centers for Disease Control and Prevention (CDC) and the Department of Veterans Affairs (VA)." Additional information regarding Sentry's GSA Contract can be found at GSA eLibrary.
Companies in this article
More in Home